All comments can be sent at [email protected]. Deadline of submission of comments shall be by 08 January 2021.
Attachment:->Draft for Comments – Supplement to FDA Circular No.2014-016 Implementing Guidelines AO2013-0022 on the Renewal of cGMP Clearance
Draft for Comments || Updates and Amendments to the List…
FDA Press Statement || Food and Drug Administration’s (FDA) Commitment…
NP-SVP(A)-2023-0293-ODG || Procurement of Bus Rental for the FDA 2023…
Civic Drive Filinvest Corporate City
(02) 8857-1900local 1000(02) 8842-5635
Copyright © 2023. All Rights Reserved.